You are here: Home » PTI Stories » National » News
Business Standard

USFDA inspects Mandideep facility of Resonance Specialties

Press Trust of India  |  New Delhi 

Resonance Specialties today said its manufacturing facility at Mandideep has been inspected by US health regulator USFDA.

One of the company's manufacturing sites -- Vista Organics Pvt, Mandideep -- has been recently inspected by the United States Food and Drug Administration (USFDA), Resonance Specialties said in a filing.



"No 483 observations have been issued and Establishment Inspection Report (EIR) is awaited," it added.

EIR is given after the successful completion of the inspection by USFDA.

The stock of Resonance Specialties today closed 4.93 per cent lower at Rs 38.60 on

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

USFDA inspects Mandideep facility of Resonance Specialties

Resonance Specialties today said its manufacturing facility at Mandideep has been inspected by US health regulator USFDA. One of the company's manufacturing sites -- Vista Organics Pvt, Mandideep -- has been recently inspected by the United States Food and Drug Administration (USFDA), Resonance Specialties said in a BSE filing. "No 483 observations have been issued and Establishment Inspection Report (EIR) is awaited," it added. EIR is given after the successful completion of the inspection by USFDA. The stock of Resonance Specialties today closed 4.93 per cent lower at Rs 38.60 on BSE. Resonance Specialties today said its manufacturing facility at Mandideep has been inspected by US health regulator USFDA.

One of the company's manufacturing sites -- Vista Organics Pvt, Mandideep -- has been recently inspected by the United States Food and Drug Administration (USFDA), Resonance Specialties said in a filing.

"No 483 observations have been issued and Establishment Inspection Report (EIR) is awaited," it added.

EIR is given after the successful completion of the inspection by USFDA.

The stock of Resonance Specialties today closed 4.93 per cent lower at Rs 38.60 on

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22

USFDA inspects Mandideep facility of Resonance Specialties

Resonance Specialties today said its manufacturing facility at Mandideep has been inspected by US health regulator USFDA.

One of the company's manufacturing sites -- Vista Organics Pvt, Mandideep -- has been recently inspected by the United States Food and Drug Administration (USFDA), Resonance Specialties said in a filing.

"No 483 observations have been issued and Establishment Inspection Report (EIR) is awaited," it added.

EIR is given after the successful completion of the inspection by USFDA.

The stock of Resonance Specialties today closed 4.93 per cent lower at Rs 38.60 on

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22